Jenoptik (ETR:JEN) reported a return to revenue growth and a sharp improvement in profitability in the first half of 2026, supported by demand in its semiconductor-focused operations and strong order activity in Biophotonics.
The company also raised the specificity of its full-year outlook, forecasting revenue growth toward the upper half of its previous range
New Chief Executive Officer Dominic Dorfner, who officially joined the company on Aug. 1, said he had begun visiting Jenoptik sites and meeting employees, customers and other stakeholders. He said photonics offers “a lot of growth potential” and that his immediate focus would be listening and gaining a fuller understanding of the business. Dorfner also said Jenoptik is conducting an update of its strategy process.
The executive board expects to communicate key findings and outcomes “towards the end of the year at the earliest,” he said. Orders and backlog rise sharply Dr. Prisca Havranek-Kosicek said group order intake rose by more than 50% year over year in the first half, exceeding management’s expectations.